Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Roche presents 4-aroylpiperidines active as chemokine receptor antagonists

June 28, 2000

Icos acquires additional rights to Abbott's LFA-1 compounds

June 27, 2000

F-1322 dropped from development after reaching phase II

June 27, 2000

Eotaxin found to regulate gastrointestinal allergic reactions

June 27, 2000

Additive or synergistic effects of surfactant and PDE4 inhibitor in acute lung injury

June 26, 2000

LM-1507.Na -- a potent and selective Cys-LT1 receptor antagonist with oral activity

June 26, 2000

Inhibitors of multiple leukotrienes in development for asthma at Czech research institute

June 23, 2000

BIIL-284: preclinical profile of a new, orally active LTB4 antagonist

June 23, 2000

Antiallergic agents from JT inhibit the production of IgE and IL-5

June 22, 2000

Three newly issued patents cover novel CCR3 receptor antagonists synthesized at SmithKline Beecham

June 21, 2000

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...